日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical Relevance of Antimicrobial Susceptibility Testing Methods in Carbapenem-Resistant Acinetobacter baumannii Pneumonia: A Secondary Analysis of a Randomized Controlled Trial

抗菌药物敏感性试验方法在耐碳青霉烯类鲍曼不动杆菌肺炎中的临床意义:一项随机对照试验的二次分析

Ungthammakhun, Chutchawan; Vasikasin, Vasin; Cheh-Oh, Nadia; Santimaleeworagun, Wichai; Changpradub, Dhitiwat

Co-Administration Dosing of Ceftazidime-Avibactam and Aztreonam in Patients with Varying Renal Function for Carbapenem-Resistant Enterobacterales Infections via Monte Carlo Simulation

通过蒙特卡罗模拟研究头孢他啶-阿维巴坦与氨曲南联合用药治疗肾功能不同的碳青霉烯耐药肠杆菌感染患者的疗效

Hemapanpairoa, Jatapat; Saelim, Weerayuth; Changpradub, Dhitiwat; Santimaleeworagun, Wichai

Impact of vancomycin area under the curve in early or later phase on efficacy and nephrotoxicity in patients with enterococcal bloodstream infections: a multicenter study

万古霉素曲线下面积在早期或晚期对肠球菌血流感染患者疗效和肾毒性的影响:一项多中心研究

Tangvichitrerk, Piyawadee; Changpradub, Dhitiwat; Hemapanpairoa, Jatapat; Juntanawiwat, Piraporn; Santimaleeworagun, Wichai

The Mortality of Colistin Monotherapy vs. Colistin-Sulbactam for Carbapenem-Resistant Acinetobacter baumannii Pneumonia: A Propensity Score Analysis

粘菌素单药治疗与粘菌素-舒巴坦治疗耐碳青霉烯类鲍曼不动杆菌肺炎的死亡率比较:倾向评分分析

Cheh-Oh, Nadia; Ungthammakhun, Chutchawan; Changpradub, Dhitiwat; Santimaleeworagun, Wichai

Optimizing Doses of Ceftolozane/Tazobactam as Monotherapy or in Combination with Amikacin to Treat Carbapenem-Resistant Pseudomonas aeruginosa

优化头孢洛扎/他唑巴坦单药治疗或与阿米卡星联合治疗耐碳青霉烯类铜绿假单胞菌感染的剂量

Nasomsong, Worapong; Nulsopapon, Parnrada; Changpradub, Dhitiwat; Pungcharoenkijkul, Supanun; Hanyanunt, Patomroek; Chatreewattanakul, Tassanawan; Santimaleeworagun, Wichai

Correction: Nulsopapon et al. The Synergistic Activity and Optimizing Doses of Tigecycline in Combination with Aminoglycosides against Clinical Carbapenem-Resistant Klebsiella pneumoniae Isolates. Antibiotics 2021, 10, 736

更正:Nulsopapon 等人,《替加环素与氨基糖苷类抗生素联合治疗临床耐碳青霉烯类肺炎克雷伯菌分离株的协同活性及剂量优化》,《抗生素》2021, 10, 736

Nulsopapon, Parnrada; Nasomsong, Worapong; Pongchaidecha, Manat; Changpradub, Dhitiwat; Juntanawiwat, Piraporn; Santimaleeworagun, Wichai

A Randomized Controlled Trial of Colistin Combined with Sulbactam: 9 g per Day versus 12 g per Day in the Treatment of Extensively Drug-Resistant Acinetobacter baumannii Pneumonia: An Interim Analysis

一项随机对照试验比较了粘菌素联合舒巴坦(每日9克与每日12克)治疗广泛耐药鲍曼不动杆菌肺炎的疗效:中期分析

Ungthammakhun, Chutchawan; Vasikasin, Vasin; Changpradub, Dhitiwat

Clinical Impact of Vancomycin Treatment in Ampicillin-Susceptible Enterococci Bloodstream Infections

万古霉素治疗对氨苄青霉素敏感肠球菌血流感染的临床影响

Hemapanpairoa, Jatapat; Changpradub, Dhitiwat; Santimaleeworagun, Wichai

Impact of Inappropriate Empirical Antibiotic on Outcomes in Community-acquired Third Generation Cephalosporin Resistant Enterobacterales Bacteremia

不恰当的经验性抗生素治疗对社区获得性第三代头孢菌素耐药肠杆菌科细菌血症预后的影响

Nasomsong, Worapong; Changpradub, Dhitiwat; Vasikasin, Vasin

The Potential Use of Ceftazidime-Avibactam Against Carbapenem Resistant Klebsiella pneumoniae Clinical Isolates Harboring Different Carbapenemase Types in a Thai University Hospital

头孢他啶-阿维巴坦在泰国某大学医院治疗携带不同碳青霉烯酶类型的耐碳青霉烯类肺炎克雷伯菌临床分离株的潜在应用

Nasomsong, Worapong; Nulsopapon, Parnrada; Changpradub, Dhitiwat; Pongchaidecha, Manat; Pungcharoenkijkul, Supanun; Juntanawiwat, Piraporn; Simsiriporn, Waristha; Santimaleeworagun, Wichai